California 2025-2026 Regular Session

California Assembly Bill AB2565

Introduced
2/20/26  
Refer
3/19/26  
Report Pass
3/19/26  
Refer
3/23/26  
Report Pass
4/22/26  
Refer
4/27/26  
Report Pass
5/6/26  
Engrossed
5/14/26  
Refer
5/14/26  

Caption

Medi-Cal: pharmacist services: reporting.

Impact

The implementation of AB 2565 is expected to improve healthcare access for Medi-Cal beneficiaries by ensuring that pharmacist services are effectively utilized and reported. By requiring comprehensive data on implementation, service access, claims processing, and the fiscal and public health impacts of pharmacist services, the bill aims to identify gaps and disparities in service delivery. This could lead to better resource allocation within the Medi-Cal program and enhanced care outcomes for low-income individuals who rely on these services.

Summary

Assembly Bill 2565, introduced by Assembly Member Wallis, pertains to the Medi-Cal program and aims to enhance the reporting requirements regarding pharmacist services provided under managed care plans. This bill requires that the department administers a more structured oversight process by mandating annual reports from Medi-Cal managed care plans about the pharmacist services they provide. Furthermore, the bill calls for a consolidated report to be submitted to the relevant legislative committees detailing this information, thereby increasing transparency and accountability for these services.

Sentiment

The sentiment surrounding AB 2565 appears largely positive, with recognition of the need for improved oversight of pharmacist services within the Medi-Cal framework. Stakeholders are hopeful that this legislation will result in increased access to essential pharmacy services, ultimately benefiting the health of Medi-Cal beneficiaries. However, there are concerns regarding the enforcement aspects of the bill, particularly about how effectively the department can oversee compliance among managed care plans.

Contention

The discussions around AB 2565 highlighted certain points of contention, particularly regarding the capacity of the department to follow through with the mandated reports and corrective actions. Critics express concerns about the feasibility of requiring managed care plans to comply with these new provisions and whether the existing infrastructure can handle the increased reporting demands. Additionally, there were discussions about the potential for administrative burden on the department and healthcare providers that could arise from these new compliance requirements.

Companion Bills

No companion bills found.

Previously Filed As

CA AB1366

Reimbursement for pharmacist services.

CA AB2571

Reimbursement for pharmacist services.

CA SB1309

Pharmacists; care standard; prescriptions

CA H1021

Administration of Medications by Pharmacists

CA HB2208

Pharmacists; pharmacies; reimbursement costs; appeals

CA HB2196

Pharmacists; pharmacies; reimbursement costs; appeals

CA HB2628

Pharmacists; emergency medication; administration

CA AB403

Medi-Cal: community health worker services.

CA H1425

Consultant Pharmacists

CA AB220

Medi-Cal: subacute care services.

Similar Bills

CA AB1366

Reimbursement for pharmacist services.

CA AB2571

Reimbursement for pharmacist services.

CA AB1503

Pharmacy.

CA AB1587

Prescription drug refills: prescriber notifications.

CA AB968

An act to amend Sections 733, 2242.

CA AB50

Pharmacists: furnishing contraceptives.

AZ HB2196

Pharmacists; pharmacies; reimbursement costs; appeals

AZ HB2208

Pharmacists; pharmacies; reimbursement costs; appeals